RxDoctor Payments Data

Jacob Mishell

Interventional Cardiology · San Francisco, CANPI 1487732004

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $21,218 of the $32,341 with a category attached, or 65.6%. 9 manufacturers reported payments, led by Edwards Lifesciences at 45.7% of the total.

$32,341in general payments, 2019–2025

Across 185 payments — averaging $174.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$15K
  • Medtronic$10K
  • Boston Scientific$5K
  • Abbott$3K
  • Shockwave Medical, Inc$76
  • Biosense Webster, Inc.$35
  • plus $60 from 3 others
$1,716,437in research payments, 2019–2025

Across 87 payments — averaging $19,729 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$1.5M
  • Abbott$255K

What the payments were for

  • Consulting fees$4,00012%
  • Travel & lodging$21,21866%
  • Food & beverage$7,12322%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,341 in reported general payments places this provider in the 80th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California

Other interventional cardiology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →